LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 62 filers reported holding LYRA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,890 | -96.6% | 6,822 | -23.5% | 0.00% | -100.0% |
| Q1 2024 | $55,488 | +348.3% | 8,921 | +277.7% | 0.00% | – |
| Q4 2023 | $12,377 | -53.2% | 2,362 | -65.1% | 0.00% | -100.0% |
| Q3 2023 | $26,439 | +346.1% | 6,762 | +368.9% | 0.00% | – |
| Q2 2023 | $5,927 | +29535.0% | 1,442 | -85.5% | 0.00% | -100.0% |
| Q1 2023 | $20 | +33.3% | 9,972 | +108.4% | 0.00% | 0.0% |
| Q4 2022 | $15 | -99.9% | 4,786 | +37.1% | 0.00% | – |
| Q3 2022 | $17,000 | +240.0% | 3,490 | +291.7% | 0.00% | – |
| Q2 2022 | $5,000 | -89.4% | 891 | -91.6% | 0.00% | -100.0% |
| Q4 2021 | $47,000 | +23.7% | 10,655 | +151.6% | 0.00% | 0.0% |
| Q3 2021 | $38,000 | +245.5% | 4,235 | +203.1% | 0.00% | – |
| Q2 2021 | $11,000 | -15.4% | 1,397 | +33.0% | 0.00% | – |
| Q1 2021 | $13,000 | -38.1% | 1,050 | -44.3% | 0.00% | -100.0% |
| Q4 2020 | $21,000 | -54.3% | 1,885 | -53.8% | 0.00% | 0.0% |
| Q3 2020 | $46,000 | +411.1% | 4,080 | +407.5% | 0.00% | – |
| Q2 2020 | $9,000 | – | 804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,222,560 | $12,955,000 | 0.26% |
| Ikarian Capital, LLC | 422,338 | $1,698,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 520,544 | $2,093,000 | 0.07% |
| Clearline Capital LP | 119,924 | $482,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,900 | $269,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,516 | $155,000 | 0.00% |
| Pentwater Capital Management LP | 60,000 | $241,000 | 0.00% |
| Worth Asset Management, LLC | 650 | $3,000 | 0.00% |
| Close Asset Management Ltd | 7,000 | $30,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $2,000 | 0.00% |